Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses uses of AI for ...

European Frontrunners Columnist, Cheryl Barton, focuses on European biotechs leveraging AI, multi-omics, and cell therapies to address the root causes of cardiovascular disease, driving a market ...

Andrew Chang and Steven Falcone, Novo Nordisk, discuss GMP mutual recognition, real-time digital monitoring, and the future ...

Understand the strategic drivers behind Tjoapack’s US expansion and how increasing packaging capacity supports growing client ...

In part 1 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains the difference ...

Andrew Chang, senior director for Quality and Regulatory Affairs, Novo Nordisk, and Steven Falcone, head of the AIR-Q Group, ...

Uhlmann Pac-Systeme highlights PTC 200 mono-cartoning for parenterals and BEC 500 blister–cartoner integration, with digital ...

Global CPHI events underscore international sourcing and partnership dynamics, with Shanghai’s CPHI & PMEC China illustrating ...

Continuous human oversight across design, validation, and operational deployment is positioned as the primary control to ...

European Biotechs are utilizing AI and precision medicines to improve the personalized treatment of cardiovascular disease.

As a part of PDA Week 2026, Christopher Lewis, Emoja Biopharma and president of the Mountain States PDA Chapter, reflects on ...